All Companies
DXCM
DexCom, Inc.Surgical & Medical Instruments & Apparatus
$89.35updated Sep 19, 2026
Congressional trading profile for DexCom, Inc. (DXCM), covering 8 disclosed transactions by 4 lawmakers.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Total Trades
8
Politicians Trading
4
Last Traded
May 7, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Michael T. McCaulR | Jun 10, 2026 | May 7, 2026 | Sell | $1,001 - $15,000 | +46.69% |
| Jefferson ShreveR | Jun 22, 2025 | May 12, 2025 | Sell | $15,001 - $50,000 | +5.06% |
| Jefferson ShreveR | Jun 22, 2025 | May 8, 2025 | Buy | $15,001 - $50,000 | +4.70% |
| Robert BresnahanR | Jun 9, 2025 | May 15, 2025 | Buy | $1,001 - $15,000 | +4.30% |
| Jefferson ShreveR | May 8, 2025 | Apr 7, 2025 | Sell | $15,001 - $50,000 | +44.98% |
| Robert BresnahanR | Apr 28, 2025 | Apr 8, 2025 | Sell | $1,001 - $15,000 | +47.22% |
| Robert BresnahanR | Mar 27, 2025 | Feb 25, 2025 | Buy | $1,001 - $15,000 | +1.17% |